CompletedNot Applicable

Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery.

Netherlands110 participantsStarted 2010-01

Plain-language summary

The ORANGE II trial is a double blinded randomised controlled trial that will provide evidence on the merits of laparoscopic surgery in patients undergoing a left lateral hepatic sectionectomy in terms of time to functional recovery, hospital length of stay, quality of life, readmission percentage, morbidity and mortality, hospital costs, body image and cosmesis, and long term incidence of incisional hernias.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients suitable for undergoing both laparoscopic left lateral sectionectomy as well as open left lateral sectionectomy of the liver. * Able to understand the nature of the study and what will be required of them. * Men and non-pregnant, non-lactating women between age 18-80. * BMI between 18-35. * Patients with ASA I-II-III Exclusion Criteria: * Inability to give written informed consent. * Patients undergoing liver resection other than left lateral hepatic sectionectomy. * Patients with ASA IV-V * Underlying liver disease

What they're measuring

Time to functional Recovery

Timeframe: Date the functional recovery criteria are met

Trial details

NCT IDNCT00874224

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Colorectal Cancer trials